debt_leverage_profile
Early-stage startup likely carries minimal formal debt; leverage ratio near 0x with equity-funded operations predominating
Inferred
Agent_Inference
interest_rate_sensitivity
Low direct sensitivity; rising rates increase cost of future equity rounds and reduce venture valuation multiples by ~20-30%
Inferred
Agent_Inference
geopolitical_supply_exposure
Low intensity; China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
supply_chain_dependency
Dependent on U.S.-based cloud infrastructure and payment rails; no significant physical goods supply chain chokepoints identified
Inferred
Agent_Inference
international_expansion_readiness
Minimal international revenue footprint; sovereign currency devaluation exposure is negligible at current stage
Inferred
Agent_Inference
geographic_footprint
Predominantly U.S.-domestic operations; limited multi-currency exposure reduces devaluation risk materially
Inferred
Agent_Inference
commodity_exposure_profile
Low intensity; commodities: Active Pharmaceutical Ingredients, Rare Earth Elements, Natural Gas (energy), Plastics/Resins, Ethanol, Packaging Materials; geopolitical: China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
vendor_lock_dependency_score
High: likely dependent on a single cloud provider (AWS or GCP) and Stripe for payments, each potentially exceeding 30% of operational input cost
Inferred
Agent_Inference
business_model_type_primary
SaaS/platform model; cloud termination would cause critical service outage requiring 60-90 day migration minimum
Inferred
Agent_Inference
business_model_type_secondary
Secondary revenue likely from transactional or professional services fees supplementing core SaaS subscriptions
Inferred
Agent_Inference
switching_cost_profile
Moderate-to-high API coupling risk if clients integrate Salspera deeply into CRM or ERP workflows; switching cost rises with integration depth
Inferred
Agent_Inference
howey_test_risk_index
Low Howey Test risk; subscription SaaS revenue model does not constitute an investment contract or profit-sharing scheme
Inferred
Agent_Inference
regulatory_burden_tier
Very High
Medium
GICS-regulatory-overlay-v1
data_sovereignty_risk
Moderate GDPR/CCPA exposure if handling customer PII; requires data processing agreements and consent mechanisms; likely not yet fully compliant
Inferred
Agent_Inference
antitrust_exposure_flag
Low antitrust risk at current scale; no dominant market position or exclusionary conduct evident
Inferred
Agent_Inference
regulatory_exposure_profile
Very High burden; regimes: FDA, CMS, HHS, HIPAA, EMA, OIG; Drug pricing legislation and approval delays directly compress revenue visibility.
Medium
GICS-regulatory-overlay-v1
revenue_model_type
Estimated 70-80% recurring SaaS subscription revenue; remainder transactional or one-time onboarding fees
Inferred
Agent_Inference
monetization_vector
Primarily seat-based or usage-based SaaS subscriptions targeting sales teams or revenue operations professionals
Inferred
Agent_Inference
pricing_architecture
Likely tiered subscription pricing (SMB/Mid-Market/Enterprise); vulnerable to compression if competitors commoditize core features
Inferred
Agent_Inference
pricing_power_rating
Moderate; pricing power contingent on workflow stickiness and differentiated analytics; limited brand moat at early stage
Inferred
Agent_Inference
target_gross_margin_bracket
Target SaaS gross margin of 70-80%; achievable if cloud infrastructure costs remain below 15% of revenue
Inferred
Agent_Inference
churn_vulnerability_index
Moderate free-rider risk if freemium tier exists; premium conversion rate likely below 5% without strong activation triggers
Inferred
Agent_Inference
headcount_cost_structure
Revenue growth is sublinear to headcount; engineering and product fixed costs scale slowly while sales headcount scales with new logo acquisition
Inferred
Agent_Inference
marginal_cost_of_growth
Marginal cost of adding new customers is low on software side; primary growth cost is sales and marketing, not infrastructure
Inferred
Agent_Inference
franchise_compliance_risk
null
Inferred
Agent_Inference
customer_acquisition_metric
At 10x scale, CAC likely compresses 20-30% via brand and referral effects; LTV:CAC ratio should improve toward 4:1 or better
Inferred
Agent_Inference
network_effect_present
Weak direct network effects currently; potential for data network effects if platform aggregates cross-customer benchmarking insights
Inferred
Agent_Inference
asset_efficiency_ratio
AI displacement risk is moderate; core sales analytics functions are automatable, requiring continuous product differentiation investment
Inferred
Agent_Inference
recession_resistance_tier
Moderate recession vulnerability; sales enablement software faces budget cuts in downturns but retains value if directly tied to revenue outcomes
Inferred
Agent_Inference
customer_segment_primary
Primary segment: SMB and mid-market sales teams or revenue operations leaders seeking pipeline management solutions
Inferred
Agent_Inference
customer_segment_secondary
Secondary segment: Enterprise sales organizations requiring advanced analytics, forecasting, or commission management capabilities
Inferred
Agent_Inference
characteristic_occupations
["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "19-0000 Life, Physical, and Social Science Occupations", "21-0000 Community and Social Service Occupations", "23-0000 Legal Occupations", "29-0000 Healthcare Practitioners and Technical Occupations", "31-0000 Healthcare Support Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "51-0000 Production Occupations"]
High
SOC-2018/GICS-overlay
agent_automatable_labor_share
0.32 (HIL — ~32% of characteristic roles agent-automatable)
Medium
SOC-2018 + agentic-exposure-v1
capital_expenditure_profile
Capital allocation weighted toward product development and GTM; minimal legacy infrastructure drag; growth-oriented capex profile
Inferred
Agent_Inference
sec_cik
0002084032
High
SEC-EDGAR
ticker
TKVA
High
SEC-EDGAR